Osteoporosis with corticosteroids
Patients with respiratory disease, particularly COPD, have an increased risk of osteoporosis due to a number of factors such as reduced physical activity (in particular walking), reduced sunlight exposure, poor diet and smoking.
Use of high dose inhaled corticosteroids, and /or frequent courses of oral steroids (more than two courses per year) exacerbate this risk (higher dosages and current usage carry greater risk).
BMD alone is not a good measure of fracture risk for patients on corticosteroids, so assessment using a tool such as FRAX is recommended.
Prophylaxis or treatment should be considered in patients with multiple risk factors and high FRAX score. Note: not all products are licensed for corticosteroid-induced osteoporosis. See chapter 6.6.2 for more information.
- First Line Drugs
- Second Line Drugs
- Specialist Initiated Drugs
- Specialist Only Drugs
- Mixed Status